Nov 20 Best Practices IV: Preclinical Outsourcing Program/Simulcast
Product News Nov 11, 2013
The BioPharma Research Council (BRC) will present its Best Practices IV: Preclinical Outsourcing, November 20, 2013 (12:30-4 pm EST), at the Conference Center at Ocean Place in Long Branch, NJ, and via Webinar.
The program will evaluate the effective use of contract research organizations (CROs) by academia, industry and nonprofit entities to develop innovative therapeutics.
"As biopharmaceuticals have developed into a 50 billion dollar a year industry, preclinical outsourcing has become a common practice," says Program Director Dolly Koltchev, PhD. "Companies have become reliant on outside, specialized services to supplement their internal research and development.
"Our speakers will present their most effective practices in preclinical outsourcing for feeding drug development pipelines, and building strong relationships that lead to advancements in curing human disease."
The scheduled presenters will provide thoughtful insight into current industry trends, as well as ideas for increasing efficiency and productivity in the preclinical process.
Utilizing modern technology to cut both the costs and risks of preclinical research are underlying themes.
Among the presenters are Rachel Lane, Ph.D., Assistant Director, Scientific Affairs, at
Alzheimer's Drug Discovery Foundation (ADDF); Kuldip Dave, Ph.D., Senior Associate Director, Research Programs, at The Michael J. Fox Foundation for Parkinson's Research (MJFF); Patrick M. Dentinger, President & CEO, Absorption Systems; and Christopher J. Kemper, Ph.D., Principal, PharmaNavigators, LLC.